Drug Delivery SIG 3

Timeslot: Friday, April 23, 2021 - 1:45pm to 3:15pm
Track: Therapeutic Delivery
Room: Virtual


The Drug Delivery Special Interest Group will deal with the science and technology of controlled release of active agents from delivery systems. Controlled drug release is achieved by the use of diffusion, chemical reactions, dissolutions or osmosis, used either singly or in combination. While the vast majority of such delivery devices are based on polymers, controlled release can also be achieved by the use of mechanical pumps. In a broader sense, controlled release also involves control over the site of action of the active agent, using the active agent using pro-drugs, targetable water soluble polymers or various microparticulate systems. Relevant aspects of toxicology, bioavailability, pharmacokinetics, and biocompatibility are also included.

Michael Mitchell, PhD
Omid Veiseh, PhD


Abstracts will be available for download on April 20, 2021.

  • 264. Intravitreal injectable hydrogel incorporating microgel for prolonged protein delivery, Si Min Lee1, Joo Young Son1, Hye Kyoung Hong2, Min Hee Ham2, Se Joon Woo, PhD2, Ki Dong Park, PhD11AJOU UNIVERSUTY, Suwon, Republic of Korea, 2Seoul National University Bundang Hospital, Seongnam, Republic of Korea

  • 265. Targeting Peptide-Mediated Delivery of siRNAs into Ovarian Cancer Cells, Serena Gilmore, Timothy Samec, M.S., Anthony Hazelton, Angela Alexander-Bryant, PhDClemson University, Clemson, SC, USA

  • 266. Using vesicle lipid domains to enhance liposomal TRAIL, Timothy Vu, Justin Peruzzi, Sraeyes Sridhar, Milan Mrksich, PhD, Neha Kamat, PhDNorthwestern University, Evanston, IL, USA

  • 268. The Development of Lubricated Drug-Eluting Composite Coatings for Endotracheal Tubes, Solaleh Miar1, Flavia Fernandes1, Yamuna Pillai1, Gregory R Dion2, Joo L Ong1, Rena Bizios1, Teja Guda11The University of Texas at San Antonio, San Antonio, TX, USA, 2U.S. Army Institute of Surgical Research, San Antonio, TX, USA